Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

RNAZ TransCode Therapeutics Inc

7,55

-0,50 (-6,21%)

01 Feb 2025 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

TransCode Therapeutics (NASDAQ:RNAZ)
Historical Stock Chart
Von Jan 2025 bis Feb 2025

Click Here for more TransCode Therapeutics Charts.

TransCode Therapeutics (NASDAQ:RNAZ)
Historical Stock Chart
Von Feb 2024 bis Feb 2025

Click Here for more TransCode Therapeutics Charts.

News TransCode Therapeutics Inc

TransCode Therapeutics Announces First Patient Dosed in Third Cohort with Lead Candidate in Phase 1 Clinical Trial
Dienstag 14 Januar 2025 (3 Wochen vor) • PR Newswire (US)

Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements
Dienstag 7 Januar 2025 (4 Wochen vor) • PR Newswire (US)

Form DEF 14A - Other definitive proxy statements
Montag 30 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 20 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Donnerstag 19 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

TransCode Therapeutics Announces Safety Review Committee Approval of Opening Third Cohort and Preliminary Results from First Cohort in Phase 1 TTX-MC138 Clinical Trial
Mittwoch 18 Dezember 2024 (1 Monat vor) • PR Newswire (US)

Form EFFECT - Notice of Effectiveness
Mittwoch 18 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Freitag 6 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 2 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split
Freitag 29 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Freitag 29 November 2024 (2 Monate vor) • Edgar (US Regulatory)

TransCode Therapeutics, Inc. Announces $8 Million Private Placement
Mittwoch 27 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Weitere TransCode Therapeutics Inc News-Artikel

Gold vs US Dollar

Deutsche Lufthansa

Invesco QQQ Trust Series 1

Health Care Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen